Hearing on "Examining FDA’s Prescription Drug User Fee Program," Subcommittee on Health (March 22, 2017)
Date:
Location:
2322 Rayburn House Office Building
The Subcommittee on Health held a hearing on Wednesday, March 22, 2017, at 10:15 a.m. in 2322 Rayburn House Office Building. The hearing is entitled “Examining FDA’s Prescription Drug User Fee Program.”
Witnesses
Livestream
Key Documents
Memorandum from Ranking Member Pallone to the Subcommittee on Health
Opening Statement of Subcommittee Ranking Member Green as prepared for delivery
Meeting Documents
Witnesses
Panel I:
Janet Woodcock, M.D.
Director, Center for Drug Evaluation and Research
U.S. Food and Drug Administration
Panel II:
Anne Pritchett
Vice President, Policy and Research
PhRMA
Kay Holcombe
Senior Vice President of Science Policy
Biotechnology Industry Organization
Jeff Allen
President & CEO
Friends of Cancer Research
Subcommittees
Issues:Health